Amanote Research

Amanote Research

    RegisterSign In

Cost of Illness Analysis of Duchenne Muscular Dystrophy in Italy

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1671
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

November 1, 2014

Authors
V. FabrianiA. MarcellusiF.S. MenniniP. Giannantoni
Publisher

Elsevier BV


Related search

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

Cost of Illness of Spinal Muscular Atrophy (SMA) in Italy

Global and Regional Health Technology Assessment
Health Policy
2019English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Bladder Dysfunction in Duchenne Muscular Dystrophy

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2003English

Airway Clearance in Duchenne Muscular Dystrophy

Pediatrics
Child HealthPediatricsPerinatology
2009English

Improved Diagnosis of Duchenne/Becker Muscular Dystrophy.

Journal of Clinical Investigation
Medicine
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy